|
Originally published In Press as doi:10.1074/jbc.M002550200 on April 14, 2000
J. Biol. Chem., Vol. 275, Issue 26, 19469-19474, June 30, 2000
Structural Characterization of the Fibroblast Growth
Factor-binding Protein Purified from Bovine Prepartum Mammary Gland
Secretion*
Rene
Lametsch ,
Jan T.
Rasmussen ,
Laust B.
Johnsen ,
Stig
Purup§,
Kristen
Sejrsen§,
Torben E.
Petersen , and
Christian W.
Heegaard ¶
From the Protein Chemistry Laboratory, Department of
Molecular and Structural Biology, University of Aarhus, Science Park,
Gustav Wieds Vej 10, DK-8000 Aarhus C and the § Danish
Institute of Animal Science, Research Centre Foulum,
DK-8830 Tjele, Denmark
A novel heparin-binding protein was
purified to homogeneity from bovine prepartum mammary gland secretion
using heparin-Sepharose chromatography and reverse-phase high
performance liquid chromatography successively. Structural information
obtained by N-terminal amino acid sequencing of a series of
proteolytically generated peptides permitted the cloning of the
corresponding cDNA. The isolated cDNA was 1170 base pairs long
and consisted of an 83-base pair 5'-untranslated region followed by a
702-base pair coding region and a 385-base pair 3'-untranslated region.
The open reading frame resulted in a protein comprising 234- amino
acid residues, including a signal sequence. Instead of
Lys24 as the predicted N terminus, Edman degradation
of the native protein revealed N-terminal processing at two sites as
follows: a primary site between Arg31-Gly32
and a secondary site between Arg51-Ser52. The
amino acid sequence showed a significant similarity with that of human
(60%) and mouse (53%) fibroblast growth factor-binding protein
(FGF-BP). Accordingly, ligand blotting experiments revealed that bovine
FGF-BP bound FGF-2. The theoretical mass of the protein predicted from
the cDNA sequence is 22.5 kDa. However, the molecular mass of the
purified protein was estimated to 28.6 kDa by mass spectrometry and 36 kDa by electrophoresis. The apparent molecular weight differences are
most likely due to post-transcriptional modifications, shown to involve
N- and O-glycosylation of Asn155
and Ser172, respectively. All 10 cysteine residues in the
protein participated in disulfide bonds, and the pattern was identified
as Cys71-Cys88,
Cys97-Cys130,
Cys106-Cys142,
Cys198-Cys234, and
Cys214-Cys222. As the 10 cysteines of the
three known FGF-BPs are positionally conserved, the disulfide bond
pattern of bovine FGF-BP may be regarded as representative for the
FGF-BP family.
*
This work was supported by grants from the Danish Dairy
Research Foundation (Danish Dairy Board) and The Danish Research and Development Program for Food Technology.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF271896.
¶
To whom correspondence should be addressed: the Protein
Chemistry Laboratory, Dept. of Molecular and Structural Biology,
University of Aarhus, Science Park, Gustav Wieds Vej 10, DK-8000 Aarhus
C, Denmark. Tel.: 45 89 42 50 93; Fax: 45 86 13 65 97; E-mail:
cwh@ imsb.au.dk.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Zhang, Y. Chen, M. R. Swift, E. Tassi, D. C. Stylianou, K. A. Gibby, A. T. Riegel, and A. Wellstein
Effect of FGF-binding Protein 3 on Vascular Permeability
J. Biol. Chem.,
October 17, 2008;
283(42):
28329 - 28337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Xie, E. Tassi, M. R. Swift, K. McDonnell, E. T. Bowden, S. Wang, Y. Ueda, Y. Tomita, A. T. Riegel, and A. Wellstein
Identification of the Fibroblast Growth Factor (FGF)-interacting Domain in a Secreted FGF-binding Protein by Phage Display
J. Biol. Chem.,
January 13, 2006;
281(2):
1137 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. West, C. G. Rees, L. Duchesne, S. J. Patey, C. J. Terry, J. E. Turnbull, M. Delehedde, C. W. Heegaard, F. Allain, C. Vanpouille, et al.
Interactions of Multiple Heparin Binding Growth Factors with Neuropilin-1 and Potentiation of the Activity of Fibroblast Growth Factor-2
J. Biol. Chem.,
April 8, 2005;
280(14):
13457 - 13464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tassi, A. Al-Attar, A. Aigner, M. R. Swift, K. McDonnell, A. Karavanov, and A. Wellstein
Enhancement of Fibroblast Growth Factor (FGF) Activity by an FGF-binding Protein
J. Biol. Chem.,
October 19, 2001;
276(43):
40247 - 40253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mongiat, J. Otto, R. Oldershaw, F. Ferrer, J. D. Sato, and R. V. Iozzo
Fibroblast Growth Factor-binding Protein Is a Novel Partner for Perlecan Protein Core
J. Biol. Chem.,
March 23, 2001;
276(13):
10263 - 10271.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|